BioSpace News Archive

AVEO Oncology provided a regulatory update following a meeting with the U.S. Food and Drug Administration to discuss results from the August 2019 overall survival analysis of the TIVO-3 trial and the Company’s proposal to proceed with a New Drug Application for tivozanib..

The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE Healthcare portfolio for U.S. patients and radiologists.

TTP Ventus Ltd, a manufacturer of high-performance, silent micropumps for medical and life science markets, has announced the introduction of a range of new pumps that extend performance, delivering higher flow rates, higher pressures, and longer lifetimes.

Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today reported financial results and recent corporate highlights for the third quarter ended September 30, 2019.

T3D Therapeutics, a clinical stage drug development company engaged in the development of T3D-959, a new orally administered treatment for Alzheimer’s disease (AD), announced today that it has closed on a $15 million financing from a cornerstone investor.

Kleo Pharmaceuticals, Inc., a unique immuno-oncology company developing next-generation synthetic bispecific compounds designed to emulate or enhance the activity of biologics, announced today that Thomas J. Lynch, Jr., MD, the former Chief Scientific Officer (CSO) of Bristol-Myers Squibb Company (BMS), joined Kleo’s Board of Directors as Chairman effective November 1, 2019.

Inovalon, a leading provider of cloud-based platforms empowering data-driven healthcare, is hosting its 12th annual ScriptMed® Conference this week at The Miami Beach EDITION in Miami Beach, Florida.

Journal of American Medical Association Publishes Study Conducted at Tennessee Oncology

Liam Kelly, President and CEO, Teleflex Incorporated, is scheduled to speak at the Stephens Nashville 2019 Investment Conference at the Omni Nashville Hotel in Nashville, TN, on Thursday, November 14, 2019 at 9:00 a.m.

DEXYCU and YUTIQ now available across the VA and on Federal Supply Schedule to benefit U.S. veterans and other government employees